The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -94.91%.However, over the last six months, we can see a stronger performance of -83.72%. Over the last 30 days, the price of ELAB has leaped by -69.56%. And in the last five days, it has fallen by -0.64%.
52-week price history of ELAB Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Elevai Labs Inc.’s current trading price is -97.81% away from its 52-week high, while its distance from the 52-week low is 19.21%. The stock’s price range during this time has been between $0.08 and $4.24. The trading volume for the Healthcare sector company’s shares reached about 14.13 million for the day, which was lower than the average daily volume of 14.43 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization vs. Financial Performance: A Comparative Study
Elevai Labs Inc. (ELAB) has experienced a quarterly decline of -80.02% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.94M and boasts a workforce of 18 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3788, with a change in price of -0.5469. Similarly, Elevai Labs Inc. recorded 9,545,060 in trading volume during the last 100 days, posting a change of -85.45%.
ELAB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ELAB stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELAB Stock Stochastic Average
Today, Elevai Labs Inc.’s raw stochastic average for the past 50 days stands at 4.81%, indicating a decline from the raw stochastic average of the last 20 days, which was 14.78%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 7.23% and 5.10% respectively.
